Unknown

Dataset Information

0

Mechanism-based inhibition of human persulfide dioxygenase by ?-glutamyl-homocysteinyl-glycine.


ABSTRACT: Hydrogen sulfide (H2S) is a signaling molecule with many beneficial effects. However, its cellular concentration is strictly regulated to avoid toxicity. Persulfide dioxygenase (PDO or ETHE1) is a mononuclear non-heme iron-containing protein in the sulfide oxidation pathway catalyzing the conversion of GSH persulfide (GSSH) to sulfite and GSH. PDO mutations result in the autosomal-recessive disorder ethylmalonic encephalopathy (EE). Here, we developed ?-glutamyl-homocysteinyl-glycine (GHcySH), in which the cysteinyl moiety in GSH is substituted with homocysteine, as a mechanism-based PDO inhibitor. Human PDO used GHcySH as an alternative substrate and converted it to GHcy-SO2H, mimicking GS-SO2H, the putative oxygenated intermediate formed with the natural substrate. Because GHcy-SO2H contains a C-S bond rather than an S-S bond in GS-SO2H, it failed to undergo the final hydrolysis step in the catalytic cycle, leading to PDO inhibition. We also characterized the biochemical penalties incurred by the L55P, T136A, C161Y, and R163W mutations reported in EE patients. The variants displayed lower iron content (1.4-11-fold) and lower thermal stability (1.2-1.7-fold) than WT PDO. They also exhibited varying degrees of catalytic impairment; the kcat/Km values for R163W, L55P, and C161Y PDOs were 18-, 42-, and 65-fold lower, respectively, and the T136A variant was most affected, with a 200-fold lower kcat/Km Like WT enzyme, these variants were inhibited by GHcySH. This study provides the first characterization of an intermediate in the PDO-catalyzed reaction and reports on deficits associated with EE-linked mutations that are distal from the active site.

SUBMITTER: Kabil O 

PROVIDER: S-EPMC6093238 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanism-based inhibition of human persulfide dioxygenase by γ-glutamyl-homocysteinyl-glycine.

Kabil Omer O   Motl Nicole N   Strack Martin M   Seravalli Javier J   Metzler-Nolte Nils N   Banerjee Ruma R  

The Journal of biological chemistry 20180706 32


Hydrogen sulfide (H<sub>2</sub>S) is a signaling molecule with many beneficial effects. However, its cellular concentration is strictly regulated to avoid toxicity. Persulfide dioxygenase (PDO or ETHE1) is a mononuclear non-heme iron-containing protein in the sulfide oxidation pathway catalyzing the conversion of GSH persulfide (GSSH) to sulfite and GSH. PDO mutations result in the autosomal-recessive disorder ethylmalonic encephalopathy (EE). Here, we developed γ-glutamyl-homocysteinyl-glycine  ...[more]

Similar Datasets

| S-EPMC4383860 | biostudies-literature
| PRJEB24175 | ENA
| S-EPMC3280726 | biostudies-literature
| S-EPMC3531769 | biostudies-literature
| S-EPMC5691403 | biostudies-literature
| S-EPMC6508711 | biostudies-literature
| S-EPMC6434940 | biostudies-literature
| S-EPMC4874178 | biostudies-literature
| S-EPMC7883896 | biostudies-literature
| S-EPMC1413787 | biostudies-literature